HCA Healthcare, Inc. (NYSE:HCA) Q2 2022 Earnings Conference Call July 22, 2022 9:00 AM ET
Company Participants
Frank Morgan - Vice President, Investor Relations
Samuel Hazen - Chief Executive Officer
William Rutherford - Executive Vice President and Chief Financial Officer
Conference Call Participants
A.J. Rice - Credit Suisse
Pito Chickering - Deutsche Bank
Ann Hynes - Mizuho Securities
Whit Mayo - SVB Securities
Gary Taylor - Cowen
Joanna Gajuk - Bank of America
Justin Lake - Wolfe Research
Ben Hendrix - RBC Capital Markets
Brian Tanquilut - Jefferies
Joshua Raskin - Nephron Research
Lance Wilkes - Bernstein
Scott Fidel - Stephens
John Mason - Raymond James
Stephen Baxter - Wells Fargo
Andrew Mok - UBS
Jason Cassorla - Citi
Sarah James - Barclays
Jamie Perse - Goldman Sachs
Operator
Welcome to the HCA Healthcare Second Quarter 2022 Earnings Conference Call. Today's call is being recorded.
At this time for opening remarks and introductions, I would like to turn the call over to Vice President of Investor Relations, Mr. Frank Morgan. Please go ahead, sir.
Frank Morgan
Good morning and welcome to everyone on today's call. With me this morning is our CEO, Sam Hazen; and CFO, Bill Rutherford. Sam and Bill will provide some prepared remarks and then we'll take questions.
Before I turn the call over to Sam. Let me remind everyone that should today's call contain any forward-looking statements they are based on management's current expectations, numerous risks, uncertainties and other factors may cause actual results to differ materially from those that might be expressed today. More information on forward-looking statements, and these factors are listed in today's press release and in our various SEC filings. On this morning's call, we may reference measure such as adjusted EBITDA, which is a non-GAAP financial measure. A table providing supplemental information on adjusted EBITDA and reconciling net income attributable
- Read more current HCA analysis and news
- View all earnings call transcripts